Related Substances Method Development and Validation of Axitinib, Zanubrutinib and Upadacitinib Using RP-HPLC and its Degradation Products were Characterized by Using LC-MS/MS

发表于 2026-9-4 13:38:23

期刊：International Journal of Pharmaceutical Investigation

文献作者：Ibrahim Baje Syed; Madhavi Nannapaneni

出版日期：2022-12-20

DOI号：10.5530/223097131696

文献链接：https://doi.org/10.5530/223097131696

当前文献来源于 Manuscript Technomedia LLP。

备注信息：

发表于 2026-9-4 13:38:24

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[其他期刊] Related Substances Method Development and Validation of Axitinib, Zanubrutinib and Upadacitinib Using RP-HPLC and its Degradation Products were Characterized by Using LC-MS/MS

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[其他期刊] Related Substances Method Development and Validation of Axitinib, Zanubrutinib and Upadacitinib Using RP-HPLC and its Degradation Products were Characterized by Using LC-MS/MS 一键复制

已采纳